Thank you for using rssforward.com! This service has been made possible by all our customers. In order to provide a sustainable, best of the breed RSS to Email experience, we've chosen to keep this as a paid subscription service. If you are satisfied with your free trial, please sign-up today. Subscriptions without a plan would soon be removed. Thank you!
Two novel drugs produced unprecedented gains in survival in separate studies of people with melanoma, the deadliest form of skin cancer, doctors reported Sunday.
By ROBERT F. WORTH 05 Jun, 2011--
Source: http://feeds.nytimes.com/click.phdo?i=9a3e91a210d6094d89b6b21f41c2eacd
~
Manage subscription | Powered by rssforward.com
Tidak ada komentar:
Posting Komentar